Somatostatin, Alzheimer's disease and cognition: an old story coming of age?
Prog Neurobiol
; 89(2): 153-61, 2009 Oct.
Article
em En
| MEDLINE
| ID: mdl-19595735
In mammalian brain, the somatostatin (SRIF: somatotropin release-inhibiting factor) family is composed of two peptides: SRIF and cortistatin (CST), which interact with five different receptor subtypes, sst(1-5). This review summarizes the properties of these receptors, the involvement of somatostatinergic systems in Alzheimer's disease (SRIF/acetylcholine (Ach), SRIF/amyloid beta peptides, and SRIF/tau interactions) and their role in cognition from early studies using cysteamine as an SRIF depleting substance to the use of subtype selective analogues and knockout mice, and modulation of synaptic plasticity. The current SRIF story illustrates how cognition and emotion are intimately integrated in brain function.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Somatostatina
/
Cognição
/
Doença de Alzheimer
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article